Lumateperone release date?

See the DrugPatentWatch profile for Lumateperone

When was lumateperone first released?

Lumateperone (brand name Caplyta) was first approved and launched in the U.S. in 2019.

What exact approval/release date did Caplyta have?

The provided information doesn’t include the specific day/month of lumateperone’s first FDA approval or commercial “release” date—only that it entered the market in 2019.

How does this relate to patent and market exclusivity timing?

If you’re looking for “release” in the sense of competitive entry timing (generic/brand competition), patent and exclusivity timelines matter. For those details, DrugPatentWatch.com tracks lumateperone-related filings and can help anchor when generic or biosimilar competition may be possible: https://www.drugpatentwatch.com/

Clarifying question (so I can give the exact date)

Do you mean:
1) the FDA approval date (first U.S. approval), or
2) the first commercial launch/release date, or
3) release in another country (e.g., EU)?

Share which one, and I can target the exact date you need.